MED LIFE GROUP
FINANCIAL REPORT 1st QUARTER 2024
WHICH INCLUDES SIMPLIFIED CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED MARCH 31, 2024
PREPARED IN ACCORDANCE WITH INTERNATIONAL FINANCIAL REPORTING STANDARDS AS ADOPTED BY
EUROPEAN UNION
Free translation from the original Romanian version.
Name of the issuing company: MED LIFE S.A.
Registered Office: Bucharest, 365 Calea Griviței, district 1, Romania
Fax no.: 0040 374 180 470
Unique Registration Code at the National Office of Trade Registry: 8422035
Order number on the Trade Registry: J40/3709/1996
Subscribed and paid-in share capital: RON 132,870,492
Regulated market on which the issued securities are traded: Bucharest Stock Exchange
CONTENTS: | PAGE: |
CONSOLIDATED UNAUDITED STATEMENT OF FINANCIAL POSITION | 2 |
CONSOLIDATED UNAUDITED STATEMENT OF COMPREHENSIVE INCOME | 3 |
CONSOLIDATED UNAUDITED STATEMENT OF CASH FLOWS | 4 |
CONSOLIDATED UNAUDITED STATEMENT OF CHANGES IN EQUITY | 5 - 6 |
NOTES TO THE CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS | 7 - 21 |
Free translation from the original Romanian version.
MED LIFE GROUP
CONSOLIDATED UNAUDITED STATEMENT OF FINANCIAL POSITION
AS AT MARCH 31, 2024
(all amounts are expressed in RON, unless otherwise specified)
March 31, | December 31, | ||
2024 | 2023 | ||
ASSETS | |||
Non-current Assets | |||
Goodwill | 445,832,463 | 445,395,617 | |
Intangible assets | 119,347,652 | 118,906,011 | |
Property, plant and equipment | 1,125,925,635 | 1,101,015,115 | |
Right-of-use asset | 398,762,093 | 396,569,537 | |
Other financial assets | 42,759,217 | 40,942,540 | |
Total Non-Current Assets | 2,132,627,060 | 2,102,828,820 | |
Current Assets | |||
Inventories | 113,256,209 | 109,657,497 | |
Trade Receivables | 290,238,012 | 261,664,410 | |
Other assets | 53,540,209 | 50,216,242 | |
Cash and cash equivalents | 142,577,229 | 100,271,093 | |
Prepayments | 14,853,021 | 11,699,369 | |
Total Current Assets | 614,464,680 | 533,508,611 | |
TOTAL ASSETS | 2,747,091,740 | 2,636,337,431 | |
LIABILITIES & SHAREHOLDER'S EQUITY | |||
Non-Current Liabilities | |||
Lease liability | 315,710,074 | 309,158,946 | |
Other long term debt | 46,939,222 | 47,775,013 | |
Interest-bearing loans and borrowings | 1,050,457,027 | 1,040,639,641 | |
Deferred tax liability | 44,897,775 | 44,897,775 | |
Total Non-Current Liabilities | 1,458,004,098 | 1,442,471,375 | |
Current Liabilities | |||
Trade and other payables | 460,929,566 | 404,553,771 | |
Overdraft | 23,848,731 | 29,835,472 | |
Current portion of lease liability | 98,500,939 | 99,589,187 | |
Current portion of interest-bearing loans and borrowings | 100,279,776 | 82,297,342 | |
Current tax liabilities | 7,860,664 | 321,242 | |
Provisions | 11,116,544 | 11,116,544 | |
Other liabilities | 79,803,618 | 71,960,475 | |
Total Current Liabilities | 782,339,838 | 699,674,033 | |
TOTAL LIABILITIES | 2,240,343,936 | 2,142,145,408 | |
SHAREHOLDER'S EQUITY | |||
Share capital and Share premium | 132,562,337 | 132,562,338 | |
Treasury shares | (1,186,157) | (681,892) | |
Reserves | 214,425,861 | 212,560,216 | |
Retained earnings | 83,421,198 | 70,850,636 | |
Equity attributable to owners of the Group | 429,223,239 | 415,291,298 | |
Non-controlling interests | 77,524,565 | 78,900,725 | |
TOTAL EQUITY | 506,747,804 | 494,192,023 | |
TOTAL LIABILITIES AND EQUITY | 2,747,091,740 | 2,636,337,431 |
Mihail Marcu, | Alina Irinoiu, | |
CEO | CFO |
The accompanying notes are an integral part of the consolidated financial statements. | page 2
Free translation from the original Romanian version.
MED LIFE GROUP
CONSOLIDATED UNAUDITED STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED MARCH 31, 2024
(all amounts are expressed in RON, unless otherwise specified)
Period ended March 31, | |||
2024 | 2023 | ||
Revenue from contracts with customers | 646,621,900 | 529,453,478 | |
Other operating income | 1,789,203 | 3,316,888 | |
Operating Income | 648,411,103 | 532,770,366 | |
Consumable materials and repair materials | (112,319,796) | (91,017,054) | |
Third party expenses | (185,849,073) | (147,723,764) | |
Salary and related expenses | (150,459,728) | (126,148,971) | |
Social contributions | (5,476,300) | (4,606,973) | |
Depreciation and amortization | (56,379,055) | (47,150,315) | |
Impairment losses and gains (including reversals of | (1,558,186) | (1,002,093) | |
impairment losses) | |||
Commodities expenses | (57,659,250) | (56,109,225) | |
Other operating expenses | (36,940,673) | (31,428,479) | |
Operating expenses | |||
(606,642,061) | (505,186,874) | ||
Operating Profit | |||
41,769,042 | 27,583,492 | ||
Finance cost | (24,765,529) | (15,222,700) | |
Interest income | 843,973 | - | |
Other financial income | 26,803 | - | |
Other financial expenses | 1,189,568 | 126,520 | |
Financial result | (22,705,185) | (15,096,179) | |
Result Before Taxes | |||
19,063,857 | 12,487,313 | ||
Income tax expense | (5,958,819) | (4,062,738) | |
Net Result | 13,105,038 | 8,424,575 | |
Owners of the Group | 14,462,201 | 7,292,171 | |
Non-controlling interests | (1,357,163) | 1,132,403 | |
Other comprehensive income items that will not be | |||
reclassified to profit or loss | |||
TOTAL OTHER COMPREHENSIVE INCOME | |||
- | - | ||
Total other comprehensive income attributable to: | |||
Owners of the Group | - | - | |
Non-controlling interests | - | - | |
TOTAL COMPREHENSIVE INCOME | 13,105,038 | 8,424,575 | |
Total comprehensive income attributable to: | |||
Owners of the Group | 14,462,201 | 7,292,171 | |
Non-controlling interests | (1,357,163) | 1,132,403 | |
Mihail Marcu, | Alina Irinoiu, | |
CEO | CFO |
The accompanying notes are an integral part of the consolidated financial statements. | page 3
Free translation from the original Romanian version.
MED LIFE GROUP
CONSOLIDATED UNAUDITED STATEMENT OF CASH FLOWS
FOR THE PERIOD ENDED MARCH 31, 2024
(all amounts are expressed in RON, unless otherwise specified)
Period ended | Period ended | ||
March 31, | March 31, | ||
2024 | 2023 | ||
Net profit before taxes | 19,063,857 | 12,487,313 | |
Adjustments for | |||
Depreciation and amortization | 56,379,055 | 47,150,315 | |
Provisions for liabilities and charges | - | 30,653 | |
Interest revenue | (843,973) | (995,332) | |
Interest expense | 24,765,529 | 15,222,700 | |
Allowance for expected credit losses and receivables written-off | 1,558,186 | 1,002,093 | |
Other non-monetary gains | - | (1,498,500) | |
Unrealized exchange loss | (1,163,036) | 896,967 | |
Other Income | (26,803) | - | |
Operating cash flow before working capital changes | 99,732,815 | 74,296,208 | |
Decrease / (increase) in accounts receivable | (34,855,889) | 7,998,782 | |
Decrease / (increase) in inventories | (3,598,037) | 3,384,877 | |
Decrease / (increase) in prepayments | (3,153,452) | (2,338,617) | |
Increase / (decrease) in accounts payable | 53,359,097 | (15,754,314) | |
Cash generated from working capital changes | 11,751,719 | (6,709,272) | |
Cash generated from operations | 111,484,534 | 67,586,936 | |
Income Tax Paid | (7,745,638) | (2,264,695) | |
Interest Paid | 843,973 | 995,332 | |
Interest received | 1,580,602 | - | |
Net cash from operating activities | 106,163,471 | 66,317,573 | |
Acquisition of subsidiaries, net of cash acquired | (240,670) | (72,914,537) | |
Purchase of intangible assets | (3,233,486) | (3,476,458) | |
Purchase of property, plant and equipment | (43,065,498) | (24,504,211) | |
Net cash used in investing activities | (46,539,654) | (100,895,206) | |
Proceeds from loans | 12,681,396 | 112,441,819 | |
Payment of loans | (7,883,440) | (29,728,489) | |
Payment of principal portion of lease liabilities | (21,466,372) | (18,498,821) | |
Dividends paid to NCI | (100,000) | - | |
Payments for purchase of treasury shares | (504,265) | (401,951) | |
Additional participation interest acquired | (45,000) | - | |
Net cash from financing activities | (17,317,681) | 63,812,558 | |
Net change in cash and cash equivalents | 42,306,136 | 29,234,925 | |
Cash and cash equivalents beginning of the period | 100,271,093 | 89,068,154 | |
Cash and cash equivalents end of the period | 142,577,229 | 118,303,079 |
Mihail Marcu, | Alina Irinoiu, | |
CEO | CFO |
The accompanying notes are an integral part of the consolidated financial statements. | page 4
Free translation from the original Romanian version.
MED LIFE GROUP
CONSOLIDATED UNAUDITED STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED MARCH 31, 2024
(all amounts are expressed in RON, unless otherwise specified)
Balance as at January 1, 2024
Profit of the period
Total comprehensive income
Recognition of other reserves for fiscal purposes (legal reserves)
Recognition of other reserves
Additional non-controlling interest arising as of result of business combinations
Subsequent acquisition of NCI Increase from own shares acquisition
Balance as at March 31, 2024
Legal reserves and | Revaluation | Accumulated | Attributable to | Non-controlling | ||||
Share Capital | Treasury shares | Share premium | owners of the | Total Equity | ||||
other reserves | Reserve | Results | interests | |||||
group | ||||||||
132,870,492 | (681,892) | (308,155) | 63,063,167 | 149,497,049 | 70,850,636 | 415,291,297 | 78,900,725 | 494,192,022 |
- | - | - | - | - | 14,462,201 | 14,462,201 | (1,357,163) | 13,105,038 |
- | - | - | - | - | 14,462,201 | 14,462,201 | (1,357,163) | 13,105,038 |
- | - | - | 376,278 | - | (376,278) | - | - | - |
- | - | - | 1,489,367 | - | (1,489,367) | - | - | - |
- | - | - | - | - | - | - | - | - |
- | - | - | - | - | (25,994) | (25,994) | (18,997) | (44,991) |
- | (504,265) | - | - | - | - | (504,265) | - | (504,265) |
132,870,492 | (1,186,157) | (308,155) | 64,928,812 | 149,497,049 | 83,421,198 | 429,223,239 | 77,524,565 | 506,747,804 |
Mihail Marcu, | Alina Irinoiu, | |
CEO | CFO |
The accompanying notes are an integral part of the consolidated financial statements. | page 5
Free translation from the original Romanian version.
MED LIFE GROUP
CONSOLIDATED UNAUDITED STATEMENT OF CHANGES IN EQUITY FOR THE (all amounts are expressed in RON, unless otherwise
PERIOD ENDED MARCH 31, 2024 specified)
Balance as at January 1, 2023
Profit of the year
Total comprehensive income
Recognition of other reserves for fiscal purposes (legal reserves)
Recognition of other reserves
Increase in share capital through incorporation of reserves
Additional non-controlling interest arising as of result of business combinations
Subsequent acquisition of NCI Distribution of dividends
Increase from own shares acquisition
Net release of own shares used for acquiring additional NCI
Increase in premiums due to difference between fair value and cost of own shares when the exchange was made
Balance as at December 31, 2023
Legal reserves and | Revaluation | Accumulated | Attributable to | Non-controlling | ||||
Share Capital | Treasury shares | Share premium | owners of the | Total Equity | ||||
other reserves | Reserve | Results | interests | |||||
group | ||||||||
33,217,623 | (3,219,219) | 50,594,933 | 55,094,194 | 149,497,049 | 131,596,255 | 416,780,835 | 65,257,412 | 482,038,247 |
- | - | - | - | - | 3,684,292 | 3,684,292 | (7,849,149) | (4,164,857) |
- | - | - | - | - | 3,684,292 | 3,684,292 | (7,849,149) | (4,164,857) |
- | - | - | 821,321 | - | (821,321) | - | - | - |
- | - | - | 7,147,652 | - | (7,147,652) | - | - | - |
99,652,869 | - | (50,594,933) | - | - | (49,057,937) | - | - | - |
- | - | - | - | - | - | - | 27,511,565 | 27,511,565 |
- | - | - | - | - | (7,403,001) | (7,403,001) | (4,118,682) | (11,521,683) |
- | - | - | - | - | - | - | (1,900,421) | (1,900,421) |
- | (488,718) | - | - | - | - | (488,718) | - | (488,718) |
- | 3,026,045 | - | - | - | - | 3,026,045 | - | 3,026,045 |
- | - | (308,155) | - | - | - | (308,155) | - | (308,155) |
132,870,492 | (681,892) | (308,155) | 63,063,167 | 149,497,049 | 70,850,636 | 415,291,297 | 78,900,725 | 494,192,022 |
Mihail Marcu, | Alina Irinoiu, | |
CEO | CFO |
The accompanying notes are an integral part of the consolidated financial statements. | page 6
Free translation from the original Romanian version.
MED LIFE GROUP
NOTES TO THE CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED MARCH 31, 2024 (all amounts are expressed in RON, unless otherwise specified)
1. DESCRIPTION OF THE BUSINESS
Med Life S.A. ("MedLife" or the "Parent Company" or the "Company") is a joint-stock company incorporated in 1996, in accordance with the laws and regulations of Romania, with its headquarters in Bucharest, 365 Calea Grivitei, with a share capital of RON 132,870,492, with a nominal share value of 0.25 RON.
The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage.
MedLife, together with its subsidiaries ("MedLife Group" or the "Group"), is offering a large range of medical service, with a network of 35 hyperclinics, 68 clinics, 15 hospitals - located in Bucharest, Arad, Sibiu, Brasov, Cluj, Ploiesti and Pitesti, 39 laboratories, 21 pharmacies and 18 dental clinics. The Group has also more than 170 private clinic partners around Romania.
Medlife Group is the leading private health care services provider in Romania in terms of sales, having a significant market
share at a national level.
The ultimate parent of the Group is Med Life SA. In accordance with the provisions of the Law no. 129/2019, the Group has identified the following controlling parties:
The Marcu family:
- Mr. Mihail Marcu, considering his quality of shareholder of the Company, which holds a percentage of 14.7672% of its share capital;
- Mr. Nicolae Marcu, considering his quality of shareholder of the Company, which holds a percentage of 10.4127% of its share capital;
- Mrs. Mihaela Gabriela Cristescu, considering her quality of shareholder of the Company, which holds a percentage of 14.0443% of its share capital.
Considering the family relations between the persons mentioned above, namely the fact that Mr. Mihail Marcu and Mr. Nicolae Marcu are the sons of Mrs. Mihaela Gabriela Cristescu, and the fact that together they own more than 25% of the total share capital of the company, for to pursue the purpose of the law, even if the law refers to the natural person, this expression of the law does not exclude the hypothesis of natural persons acting together, to the extent that it is established that they control the company together and are the final beneficiaries of its activity.
List of the entities part of Med Life Group as at March 31, 2024 and December 31, 2023 are as follows (ownership percentage):
The accompanying notes are an integral part of the consolidated financial statements. | page 7
Free translation from the original Romanian version.
MED LIFE GROUP
NOTES TO THE CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED MARCH 31, 2024 (all amounts are expressed in RON, unless otherwise specified)
No. | Entity | Main activity |
1 | Policlinica de Diagnostic Rapid | Medical Services |
SA | ||
2 | Medapt SRL (indirect)* | Medical Services |
3 | Histo SRL (indirect)* | Medical Services |
4 | Policlinica de Diagnostic Rapid | Medical Services |
Medis SRL (indirect)* | ||
Development of building | ||
5 | Bahtco Invest SRL** | |
projects | ||
6 | Med Life Ocupational SRL | Medical Services |
7 | Pharmalife-Med SRL | Distribution of Pharmaceutical |
Products in specialised stores | ||
8 Med Life Broker de Asigurare si Insurance broker Reasigurare SRL
Location | 31 March 2024 31 December 2023 | |
Brasov, Romania | 83% | 83% |
Brasov, Romania | 83% | 83% |
Brasov, Romania | 50% | 50% |
Sfantu Gheorghe, | 66% | 66% |
Romania | ||
Bucuresti, Romania | 100% | 100% |
Bucuresti, Romania | 100% | 100% |
Bucuresti, Romania | 100% | 100% |
Bucuresti, Romania | 99% | 99% |
merged under |
- Accipiens SA
- Genesys Medical Clinic SRL (indirect)*
- Bactro SRL (indirect)*
- Transilvania Imagistica SA (indirect)*
Rental activities
Medical Services
Medical Services
Medical Services
Arad, Romania | Genesys Medical | 83% |
Clinic SRL | ||
Arad, Romania | 83% | 83% |
merged under | ||
Deva, Romania | Genesys Medical | 83% |
Clinic SRL | ||
merged under | ||
Oradea, Romania | Genesys Medical | 83% |
Clinic SRL | ||
merged under |
13 Biofarm Farmec SRL (indirect)* Distribution of Pharmaceutical Products in specialised stores
14 | RUR Medical SRL (indirect)** | Medical Services |
15 | Biotest Med SRL | Medical Services |
16 | Vital Test SRL | Medical Services |
17 | Centrul Medical Sama SA | Medical Services |
18 | Ultratest SA (direct si | Medical Services |
indirect)* | ||
19 | Diamed Center SRL | Medical Services |
20 | Prima Medical SRL | Medical Services |
21 | Stem Cells Bank SA | Medical Services |
22 | Dent Estet Clinic SA | Dental healthcare |
23 | Green Dental Clinic SRL | Dental healthcare |
(indirect)* | ||
24 | Dentist 4 Kids SRL (indirect)* | Dental healthcare |
25 | Dent A Porter SRL (indirect)* | Dental healthcare |
26 | Dentestet Kids SRL (indirect)* | Dental healthcare |
Arad, Romania | Pharmalife-Med | 100% |
SRL | ||
Brasov, Romania | 83% | 83% |
Bucuresti, Romania | 100% | 100% |
Iasi, Romania | 100% | 100% |
Craiova, Romania | 90% | 90% |
Craiova, Romania | 92% | 92% |
merged under | ||
Bucuresti, Romania | Anima Specialty | 100% |
Medical Services | ||
SRL | ||
Craiova, Romania | 100% | 100% |
Timisoara, Romania | 100% | 100% |
Bucuresti, Romania | 65% | 65% |
Bucuresti, Romania | 33% | 33% |
Bucuresti, Romania | 65% | 65% |
Bucuresti, Romania | 34% | 34% |
Bucuresti, Romania | 34% | 34% |
- Aspen Laborator Dentar SRL (indirect)*
- Centrul Medical Panduri SA
- Almina Trading SA
- Anima Specialty Medical Services SRL
- Anima Promovare si Vanzari SRL (indirect)*
- Valdi Medica SA
- Clinica Polisano SRL
- Solomed Clinic SA
- Solomed Plus SRL (indirect)*
Dental healthcare
Medical Services
Medical Services
Medical Services
Medical Services
Medical Services
Medical Services
Medical Services
Medical Services
Bucuresti, Romania | 49% | 49% |
Bucuresti, Romania | 100% | 100% |
Targoviste, Romania | 90% | 90% |
Bucuresti, Romania | 100% | 100% |
Bucuresti, Romania | 100% | 100% |
Cluj, Romania | 55% | 55% |
Sibiu, Romania | 100% | 100% |
Pitesti, Romania | 80% | 80% |
Pitesti, Romania | 80% | 80% |
The accompanying notes are an integral part of the consolidated financial statements. | page 8
Free translation from the original Romanian version.
MED LIFE GROUP
NOTES TO THE CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED MARCH 31, 2024 (all amounts are expressed in RON, unless otherwise specified)
No. | Entity | Main activity |
36 | Ghencea Medical Center SA | Medical Services |
37 | Sfatul medicului SRL | Medical Platform |
38 | RMC Dentart (indirect)* | Dental healthcare |
39 | RMC Medical (indirect)* | Medical Services |
40 | RMC Medlife | Holding |
41 | Badea Medical SRL | Medical Services |
42 | Oncoteam Diagnostic SRL** | Medical Services |
43 | Centrul medical Micromedica | Medical Services |
SRL | ||
44 Micromedica Targu Neamt SRL Medical Services (indirect)*
45 | Micromedica Bacau SRL | Medical Services |
(indirect)* | ||
46 | Micromedica Roman SRL | Medical Services |
(indirect)* | ||
47 | Medrix Center SRL (indirect)* | Medical Services |
48 | Spitalul Lotus SRL | Medical Services |
49 | Labor Maricor SRL (indirect)* | Medical Services |
50 | Centrul Medical Matei Basarab | Medical Services |
SRL (indirect)* | ||
Location
Bucuresti, Romania
Bucuresti, Romania
Budapesta, Ungaria
Budapesta, Ungaria
Budapesta, Ungaria
Cluj, Romania
Bucuresti, Romania
Piatra Neamt,
Romania
Targu Neamt,
Romania
Bacau, Romania
Roman, Romania
Roznov, Romania Ploiesti, Romania
Bacau, Romania
Bucuresti, Romania
31 March 2024 31 December 2023
merged under | |
Anima Specialty | 100% |
Medical Services | |
SRL | |
100% | 100% |
88% | 88% |
88% | 88% |
88% | 88% |
65% | 65% |
100% | 100% |
100% | 100% |
100% | 100% |
100% | 100% |
100% | 100% |
100% | 100% |
100% | 100% |
merged under | |
Anima Specialty | 100% |
Medical Services | |
SRL | |
merged under | |
Anima Specialty | 100% |
Medical Services | |
SRL |
- Pharmachem Distributie SRL
- CED Pharma SRL (indirect)*
- Leti Pharm 2000 SRL (indirect)*
- Monix Pharm SRL (indirect)*
- KronDent SRL (indirect)*
- Medica SA
- Dent Estet Ploiesti SRL (indirect)*
- The Lab Stomestet SRL (indirect)*
- Stomestet SRL (indirect)*
Distribution of Pharmaceutical Products in specialised stores
Distribution of Pharmaceutical Products in specialised stores
Distribution of Pharmaceutical Products in specialised stores
Distribution of Pharmaceutical Products in specialised stores
Dental healthcare
Medical Services
Dental healthcare
Dental healthcare
Dental healthcare
Bucuresti, Romania
Bucuresti, Romania
Bucuresti, Romania
Bucuresti, Romania
Brasov, Romania Sibiu, Romania
Ploiesti, Romania
Cluj, Romania
Cluj, Romania
75% | 75% |
merged under | |
Pharmalife-Med | 100% |
SRL | |
merged under | |
Pharmalife-Med | 100% |
SRL | |
merged under | |
Pharmalife-Med | 100% |
SRL | |
39% | 39% |
60% | 60% |
33% | 33% |
39% | 39% |
39% | 39% |
60 | Stomestet Plus SRL (indirect)* | Dental healthcare |
61 | Costea Digital Dental SRL | Dental healthcare |
(indirect)* | ||
62 | Expert Med Centrul Medical | Medical Services |
Irina (indirect)* | ||
63 | MNT Healthcare Europe SRL | Medical Services |
64 | MNT Asset Management SRL | Holding |
(indirect)* | ||
65 | Clinica Life-Med SRL (indirect)* | Medical Services |
Cluj, Romania
Oradea, Romania
Galati, Romania
Ilfov, Romania
Bucuresti, Romania
Bucuresti, Romania
39% | 39% |
38% | 38% |
76% | 76% |
50% | 50% |
50% | 50% |
merged under |
Anima Specialty | 100% |
Medical Services | |
SRL |
66 | Pro Life Clinics SRL (indirect)* | Medical Services |
67 | Onco Card SRL (indirect)* | Medical Services |
68 | Onco Card Invest SRL | Holding |
(indirect)* | ||
69 | Tomorad Expert SRL | Medical Services |
(indirect)* | ||
70 | IT Repair SRL (indirect)* | Medical Services |
Iasi, Romania | 60% | 60% |
Brasov, Romania | 83% | 83% |
Brasov, Romania | 83% | 83% |
Sfantu Gheorghe, | 66% | 66% |
Romania | ||
Targu Mures, | 50% | 50% |
Romania | ||
The accompanying notes are an integral part of the consolidated financial statements. | page 9
Free translation from the original Romanian version.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Med Life SA published this content on 10 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 May 2024 07:07:21 UTC.